Semax is a synthetic heptapeptide analogue of the ACTH(4-10) sequence, studied for its neurotrophic and neuroprotective properties across decades of published neurological research. Published research demonstrates that Semax upregulates brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression in the hippocampus and cortex in research models. This neurotrophic mechanism has made Semax a subject of neuroprotection and cognitive research in preclinical settings. Russian neurological research programs have produced decades of clinical data examining Semax across stroke recovery, neurodegeneration models, and cognitive research applications. This accumulated publication record is among the most extensive for any synthetic ACTH analogue. The dopaminergic modulation properties of Semax have also attracted research interest in models examining mood and motivation pathways. For researchers studying neurotrophic signaling, neuroprotection mechanisms, or BDNF/NGF regulation, Semax offers a well-documented research profile across preclinical and clinical literature. For research use only.
Batch documentation ships with every order. To match your vial's lot number, request the current lot COA from the product page.